By V. Virvilis and E. Lekka The latest release of Biovista Vizit (January 2025) brings a few precious features especially relevant to our AOP users. The full changelog is also available. Note that Biovista Vizit is a free official 3rd party tool listed in the AOP-Wiki. The highlight of this release is the separation of … Read More
Proud to see that our effort is acknowledged in the very interesting upcoming book: OBO Semantic Engineer Training. The contribution was exemplified as best practice in the “How to be an Open Science Engineer – maximising impact for a better world” chapter. The work was made under the auspice of CIAO project and was part … Read More
Biovista combines augmented and artificial intelligence to drive new possibilities for safer, more-precise medicines. See here for more…
Partnership Joins Protein Sequencing Technology With AI Visualization to Further Unlock the Human Proteome for Novel Drug Discovery Key Takeaways January 09, 2023 08:00 AM Eastern Standard Time GUILFORD, Conn.–(BUSINESS WIRE)–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it entered into a partnership and license agreement with … Read More
Eftychia Lekka, Ph.D. and Vassilis Virvilis, Ph.D Biovista Efforts to standardize important concepts and relationships using established Terminologies in the AOP Knowledge Base at NIH’s Predictive Toxicology Branch DNTP Seminar on Friday June 24 2022. The presentation will summarize a systematic approach on reviewing and categorizing user-entered data issues in the Adverse Outcome Pathway (AOP) … Read More